Kelley Coffman

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Cecilia Monge, Changqing Xie, Yuta Myojin et al. · Journal for ImmunoTherapy of Cancer · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Changqing Xie, M. Cecilia Monge B., Donna Mabry‐Hrones et al. · Journal of Clinical Oncology · 2023 · 17 citations

Life Sciences, Immunology, Oncology +11

Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE

Nitya Raj, Kelley Coffman, Tiffany Le et al. · Neuroendocrinology · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Kelley Coffman, Yuta Myojin, Cecilia Monge et al. · Journal for ImmunoTherapy of Cancer · 2024 · 11 citations · Full text

Medicine, Immunology, Oncology +17

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cecilia Monge, Changqing Xie, Yuta Myojin et al. · Cancer Medicine · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17